Hualan Bio genetic engineering vaccines and other high-tech products
Hualan Bio Vaccine is a modern vaccine manufacturer, mainly developing and producing human bacterial vaccines, viral vaccines, genetic engineering vaccines and other high-tech products. With advanced production equipment, testing laboratory, laboratory animal center and its affiliated facilities, it can meet the demand for vaccine products in epidemic-stricken areas in a short time.
EqualOcean Sector Quarterly Report - Healthcare Sectors
To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.
Apr 07, 2022 01:44 PM
ResearchHealthcare, Consumer Staples, Technology
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchHealthcare, Technology, Consumer Discretionary
Tech for Global, Globalization Footprints of the Established and the New
Biopharmaceutical Firm Sinogen Raises Tens of Millions of US in Pre-Series B Round
Founded in 2016, Sinogen has established a technology platform to study the mechanisms of an oncolytic virus targeting tumor cells and completed the preclinical study of SGN1, genetic engineering product that can accurately and rapidly dissolve tumors.
May 24, 2022 07:45 PM
Junshi Announces Its Anti-Covid Phase III Drug Reaches Primary Endpoint
Founded in August 2021, Juntuo Biotech is dedicated to the R&D processes in biomedicine and vaccines. The company's innovative R&D pipelines cover viral vaccines, bacterial vaccines, genetically engineered vaccines, conjugate vaccines, and multivalent vaccines.
May 24, 2022 03:45 PM